药物出产辨(十二)

382[青皮]产广东新会. 主治:苦、辛,温.破坚癖,散气滞,治左胁肝经积气.(元素) 383[柿霜]产山东、河南.有柿出者便有柿霜出. 主治:甘,平,涩.开胃涩肠,消痰止渴. 384[大腹皮]产广东琼属、嘉积、海南等处. 主治:辛,温.无毒.下一切气,止霍乱,通大小便,健脾开胃.《大明》 385[苦果]西名苦实把.一名吕宋果.西药名厄泥沙.此药产吕宋海岛.味苦,功用详《万国药方》卷五,九十九篇.     

药物出产辨(十八)

513[斑蝥]各省均有出.广东以清远、石角、北江、惠州均有出.此乃花生虫也.该处有花生种植者,便有出也.西药名甘道□思.功用详《万国药方》卷四,二十一篇. 主治:辛,寒.有毒.外用蚀死肌,敷疥癞恶疮.内用破石淋,拔瘰疬疔肿.下□犬毒,溃肉,堕胎.《本草备要》 514[竹蜂]广东惠州产者最多.乃瓜棚之乌蜂也.广西亦有出.     

四川乌头属一新种和一新变种

目的 拓展新药源.方法 野外调查和采集.结果 对采自四川省会理县龙帚山的乌头属标本与其近缘种进行对比鉴别,认定1新种1新变种.结论 龙帚山乌头Aconitum longzhoushanense W.J.Zhang et G.H.Chen,sp.nov.为一个新种;长柄铁棒锤Aconitum flavum Hand.-Mazz.vat.longipetiolatum W.J.Zhang et G.H.Chen,var.nov.为一个新变种.     

征订启事

《中国药理学通报》是由中国科协主管、中国药理学会主办的学术性月刊。主要刊登国内药理学研究论文。网址:http://www.zgylxtb.cn,http://ylx.ahmu.edu.cn,http://yaol.chinajournal.net.cn,http://zgylxtb.periodicals.net.cn。     

中药龙胆原植物的调查与鉴定

全国范围的商品调查和产地的标本采集与原植物鉴定研究表明,目前使用的中药龙胆来源于龙胆科龙胆属的九种植物,即东北龙胆Gentiana manshurica Kitag.建德龙胆G.manshurica Kitag.ssp.jiandeensis J.P.Luo et Z.C.Lou(ssp.nov.),龙胆G.scabra Bunge,三花龙胆G.triflora Pall.,坚龙胆G.rigescens Franch.,头花龙胆G.cephalantha Franch.,亚木龙胆G.suffrutescens J.P.Luo et Z.C.Lou(sp.nov.),德钦龙胆G.atuntsiensis W.W.Sm.和红花龙胆G.rhodantha Franch.。研究和比较了上述九种植物叶的组织构造特征,编写了原植物形状分种检索表和叶的显微特征分种检索表。     

在线过程分析技术在抗生素等药物结晶中的应用

Shah R B,Tawakkul M A,Khan M A.Process analytical technology:Chemometric analysis of Raman and near infrared spectroscopic data for predicting physical properties of extended release matrix tablets[J].J Pharm Sci,2007,96(5):1356-1365.

Mafalda Cruz Sarraguc,Joao Almeida Lopes.Quality control of pharmaceuticals with NIR:From lab to process line[J].Vibr Spec,2009,49(2):204-210.

Zidan A S,Habib M J,Khan M A.Process analytical technology:Nondestructive evaluation of cyclosporine A and phospholipid solid dispersions by near infrared spectroscopy and imaging[J].J Pharm Sci,2008,97(8):3388-3399.

El-Hagrasy A S,Delgado-Lopez M,Drennen J K.A process analytical technology approach to near-infrared process control of pharmaceutical powder blending:Part Ⅱ:Qualitative near-infrared models for prediction of blendhomogeneity[J].J Pharm Sci,2006,95(2):407-421.

Pollanen K,Hakkinen A,Reinikainen S P,et al.IR spectroscopy together with multivariate data analysis as a process analytical tool for in-line monitoring of crystallization process and solid-state analysis of crystalline product[J].J Pharm Biomed Anal,2005,38(2):275-284.

O' Brien L E,Timmins P,Williams A C.Use of in situ FT-Raman spectroscopy to study the kinetics of the transformation of carbamazepine polymorphs[J].J Pharm Biochera Anal,2004,36(2):335-340.

Savolainen M,Kogermann K,Heinz A,et al.Better understanding of dissolution behaviour of amorphous drugs by in situ solid-state analysis using Raman spectroscopy[J].Europ J Pharm Biopharm,2009,71(1):71-79.

Yu Q Z,Chou P S,Tan R B H.Application of attenuated total reflectance-fourier transform infrared technique in the monitoring and control of anti-solvent crystallization[J].Ind Eng Chem Res,2006,45(1):439-444.

Chen Z P,Morris J,Borissova A,et al.On-line monitoring of batch cooling crystallization of organic compounds using ATR-FTIR spectroscopy coupled with an advanced calibration method[J].Chemometr Intell Lab Syst,2009,96(1):49-58.

Matthews H B.Model identification and control of batch crystallization for an industrial chemical system[D].Ph.D.Thesis,University of Wisconsin,1997.

Scholl J,Bonalumi D,Lars Vicum,et al.In situ monitoring and modeling of the solvent-mediated polymorphic transformation of L-glutamic acid[J].Cryst Grow Des,2006,6(4):881-891.

张延会,吴良平,孙真荣.拉曼光谱技术应用进展[J].化学教学,2006,4:32-35.

Sulub Y,Lo Brutto R,Vivilecchia R,et al.Content uniformity determination of pharmaceutical tablets using five near-infrared reflectance spectrometers:A process analytical technology(PAT)approach using robust multivariate calibration transfer algorithms[J].Aanal Chim Acta,2008,611(2):143-150.

Hansman D S,Cambron R T,Sakr A.Application of online Raman spectroscopy for characterizing relationships between drug hydration state and tablet physical stability[J].Intern J Pharm,2005,299:19-33.

Fevotte G.In situ raman spectroscopy for in-line control of pharmaceutical crystallization and solids elaboration processes:A review[J].Chem Eng Res Des,2007,85(A7):906-920.

Tian F,Qu H,Louhi-Kultanen M,et al.Mechanistic insight into the evaporative crystallization of two polymorphs of nitrofurantoin monohydrate[J].J Cryst Growth,2009,311(8):2580-2589.

Xiang-Shan Li,Jie-Xin Wang,Zhi-Gang Shen,et al.Preparation of uniform prednisolone microcrystals by a controlled microprecipitation method[J].Intern J Pharm,2007,342(1-2):26-32.

Hu Y,Wikstrom H,Byrn S R,et al.Estimation of the transition temperature for an enantiotropic polymorphic system from the transformation kinetics monitored using Raman spectroscopy[J].J Pharm Biomed Anal,2007,45(4):546-551.

Starbuck C,Spartalis A,Wai L,et al.Process optimization of a complex pharmaceutical polymorphic system via in situ raman spectroscopy[J].Cryst Growth Des,2002,2(5):515-522.

Seefeldt K,Miller J,Alvarez-nunez F,et al.Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy,spectroscopy and calorimetry studies[J].J Pharm Sci,2007,96(5):1147-1158.

范少杰.太赫兹技术概述及其应用[J].电光系统,2008,2:62-64.

Wu H,Heilweil E J,Hussain A S,et al.Process analytical technology(PAT):Effects of instrumental and compositional variables on terahertz spectral data quality to characterize pharmaceutical materials and tablets[J].Intern J Pharm,2007,343(1-2):148-150.

Liu H,Chen Y,Zhang X C.Characterization of anhydrous and hydrated pharmaceutical materials with thz time-domain spectroscopy[J].J Pharm Sci,2007,96(4):927-934.

Fischer B,Hoffmann M,Helm H,et al.Chemical recognition in terahertz time-domain spectroscopy and imaging[J].Seraicond Sci Technol,2005,20(7):S246-S253.

Strachan C J,Taday P F,Newnham D A,et al.Using terahertz pulsed spectroscopy to quantify pharmaceutical polymorphism and crystallinity[J].J Pharm Sci,2005,94(4):837-846.

Gvishi R,Englander A,Peleg G.Multi-parameter evaluation of fast sol-gel process by terahertz measurements[J].J Sol Gel Sci Technol,2008,48(1-2):18-23.

胡永生,陈钱.太赫兹技术及其应用研究的进展[J].红外,2006,27(1):11-15.

张兴宁,陈稷,周泽魁.太赫兹时域光谱技术[J].激光与光电子学进展,2006,42(7):35-38.

X射线衍射分析的实验方法及其应用[OL].http://www.ms17.cn/jszx/2008/0321/article 852.html.

Blagden N,Davey R,Song M,et al.A novel batch cooling crystallizer for in situ monitoring of solution crystallization using energy dispersive X-ray diffraction[J].Cryst Growth Des,2003,3(2):197-201.

Pyne A,Suryanarayanan R.The effect of additives on the crystallization of cefazolin sodium during freeze-drying[J].Pharm Res,2003,20(2):283-291.

Pyne A,Surana R,Suryanarayanan R.Crystallization of mannitol below Tg during freeze-drying in binary and ternary aqueous systems[J].Pharm Res,2002,19(6):901-908.

Pyne A,Suryanarayanan R.Phase transitions of glycine in frozen aqueous solutions and during freeze-drying[J].Pharm Res,2001,18(10):1448-1454.

Davis T D,Morris K R,Huang H,et al.In situ monitoring of wet granulation using online X-ray powder diffraction[J].Pharm Res,2003,20(11):1851-1857.

杨传铮,汪保国,张建.二维X射线衍射及其应用研究进展[J].物理学进展,2007,27(1):69-81.

Cooke P M.Chemical microscopy[J].Anal Chem,2000,72(12):169-188.

Matthews H,Rawlings J.Batch crystallization of a photochemical:modeling,control,and filtration[J].AICHE J,1998,44(5):1119-127.

Mirza S,Heinamaki J,Miroshnyk I,et al.Understanding processing-induced phase transformations in erythromycin-PEG 6000 solid dispersions[J],d Pharm Sci,2006,95(8):1723-1732.

Fielden I M,Rodenburg J M.A technique for real-time,in situ SEM observation of grain growth at elevated temperatures[J].Recrystal Grain Growth,Pts 1 and 2,2004,467-470:1385-1388.

P.Mura,M.T.Faucci,A.Manderioli,et al.Compatibility study between ibuproxam and pharmaceutical excipients using differential scanning calorimetry,hot-stage microscopy and scanning electron microscopy[J],J Pharm Biomed Anal,1998,18(1-2):151-163.

Bikiaris D,Papageorgiou G Z,Stergiou A,et al.Physicochemical studies on solid dispersions of poorly watersoluble drugs Evaluation of capabilities and limitations of thermal analysis techniques[J].Thermochimica Acta,2005,439(1-2):58-67.

Krumme A.Measuring crystallization kinetics of high density polyethylene by improved hot-stage polarized light microscopy[J].Polymer Testing,2004,23(1):29-34.

Yu Z Q,Tan R B H,Chow P S.Effects of operating condition on agglomeration and habit of paracetamol crystal in anti-solvent crystallization[J],d Cryst Growth,2005,279(3-4):477-488.

Sheikhzadeha M,Trifkovica M,Rohani S.Real-time optimal control of an anti-solvent isothermal semi-batch crystallization process[J].Chem Eng Sci,2008,63(3):829-839.

Kougoulos E,Jones A G,Wood-kaczmar M W.Estimation of crystallization kinetics for an organic fine chemical usinga modified continuous coolingmixed suspension mixed product removal(MSMPR)crystallizer[J],d Cryst Growth,2005,273(3-4):520-528.

Dang L,Wei H,Zhu Z,et al.The influence of impurities on phosphoric acid hemihydrate crystallization[J].J Cryst Growth,2007,307(1):104-111.

O'Sullivan B,Barrett P,Hsiao G,et al.In situ monitoring of polymorphic transitions[J].Org Proc Res Dev,2003,7(6):977-982.

Kougoulos E,Jones A G,Wood-Kaczmar M W.Modelling particle disruption of an organic fine chemical compound using Lasentec focussed beam reflectance monitoring(FBRM)in agitated suspensions[J].Power Technol,2006,155(2):153-15.

Barrett P,Glennon B,O' Sullivan B.Solubility Curve and Metastable Zone Width Using Lasentec FBRM and PVM[J],Chemi Eng,2002,80(A7):799-805.

Doki N,Seki H,Takano K.Process control of seeded batch cooling crystallization of the metastable α-form glycine using an in-situ ATR-FTIR spectrometer and an in-situ FBRM particle counter[J].Cryst Growth Des,2004,4(5):949-953.

张海涛.头孢噻肟钠结晶技术研究[D].天津大学,2008.

谌怡.克林霉素磷酸酯结晶过程研究[D].天津大学,2008.

武洁花.头孢唑林钠结晶过程研究[D].天津大学,2008.

苏敏.直通法生产6-APA系统过程研究[D].天津大学,2009.

王永莉.头孢哌酮钠间歇结晶过程优化研究[D].天津大学,2009.

王占忠.红霉素结晶过程研究[D].天津大学,2007.

>>更多...     

本刊论文入选“中国百篇最具影响国内学术论文”

1.朱英杰,陈士林,姚辉,谭睿,宋经元,罗焜,鲁静.重楼属药用植物DNA条形码鉴定研究.2010,45(3):376-382.2.孙国祥,胡玥珊,毕开顺.系统指纹定量法评价牛黄解毒片质量.2009,44(4):401-405.     

敬告读者

<正>本刊免费全文开放存取网址:http://www.zgylxtb.cn;http://ylx.ahmu.edu.cn;还可查阅http://yaol.china-journal.net.cn;http://zgylxtb.periodicals.net.cn,欢迎垂询。从1999年起,本刊连续获中国科学技术协会和国家     

敬告读者

<正>本刊免费全文开放存取网址:http://www.zgylxtb.cn;http://ylx.ahmu.edu.cn;还可查阅http://yaol.china-journal.net.cn;http://zgylxtb.periodicals.net.cn,欢迎垂询。从1999年起,本刊连续获中国科学技术协会和国家     

敬告读者

<正>本刊免费全文开放存取网址:http://www.zgylxtb.cn;http://ylx.ahmu.edu.cn;还可查阅http://yaol.china-journal.net.cn;http://zgylxtb.periodicals.net.cn,欢迎垂询。从1999年起,本刊连续获中国科学技术协会和国家     

毛细管电泳紫外检测法同时测定白术中白术内酯Ⅱ和白术内酯Ⅲ含量

目的建立同时测定白术中白术内酯Ⅱ、Ⅲ的毛细管电泳紫外检测方法,并测定白术样品中白术内酯Ⅱ、Ⅲ的含量。方法采用毛细管区带电泳法,紫外检测波长254 nm,缓冲液硼酸-硼砂体积比为5∶1,分离电压15 kV,柱温20℃,电动进样10 s。结果在最优条件下,白术内酯Ⅱ、Ⅲ完全分离;在线性范围内与峰面积线性关系良好,白术内酯Ⅱ线性方程为Y=2724.5X-54.078（r=0.9958）,白术内酯Ⅲ的线性方程为Y=244.65X＋201.8（r=0.9995）,检测限（S/N=3）为0.2和1.0μg/ml。结论毛细管电泳紫外检测法可用于白术中白术内酯Ⅱ、Ⅲ的含量测定。     

反相高效液相色谱测定丹参注射剂的三种有效成分

本文用反相高效液相色谱法,采用离子抑制技术分离了丹参注射剂中三种有效成分:丹参素、原儿茶醛、原儿茶酸。并用外标法测定了它们在丹参注射液和复方丹参注射液中的含量。考察了Waters公司分析柱(3.9×300 mm)和径向加压柱(8×100 mm),以及国产色谱柱(5×150mm)分析样品,均能获得满意的结果。比较了用多通道紫外吸收检测器和254nm固定波长紫外检测器测定样品时灵敏度的差异。     

高效液相色谱法测定复方盐酸二甲双胍片中盐酸二甲双胍及格列本脲含量

目的测定复方盐酸二甲双胍中盐酸二甲双胍及格列本脲的含量。方法优化高效液相色谱法条件。 (1)盐酸二甲双胍的色谱条件是 :色谱柱 :HypersilCN(2 0 0mm× 4 6mm ,5 μm,大连依利特 ) ;流动相 :乙腈 - 0 0 0 5mol·L-1NH4H2 PO4(pH 3 5 ,5 3∶4 7) ;检测波长 :2 34nm ;柱温 :35℃ ;流速 :1 0mL·min-1。 (2 )格列本脲的测定 :色谱柱 :HypersilODS柱 (2 0 0mm× 4 6mm ,5 μm,大连依利特 ) ;流动相 :甲醇 - 0 0 0 5mol·L-1NH4H2 PO4(pH3 5 ,5∶3) ;检测波长 :30 0nm ;柱温 :35℃ ;流速 :1 0mL·min-1。结果盐酸二甲双胍和格列本脲的线性范围分别为 5 0～ 5 0 0mg·L-1和4 1 2～ 16 4 8mg·L-1;RSD均不超过 1% ;盐酸二甲双胍质量分别为 80 1、10 0 2、12 0 7μg的回收率分别为 99 9%、10 0 1%、10 0 0 % ,格列本脲质量分别为 80 2 4、10 0 30、12 0 36 μg的回收率分别为 10 1 0 %、99 7%、10 0 2 % ;最低检测限分别为 0 2 0和 0 80mg·L-1。结论本法适于复方盐酸二甲双胍的含量测定     

HPLC法测定头孢克洛颗粒剂含量

本文采用反相ＨＰＬＣ法测定头孢克洛颗粒剂含量．用ＯＤＳ－Ｃ１８柱，磷酸盐缓冲液（ｐＨ４．５）：乙腈（９４∶６）为流动相，检测波长２６５ｎｍ，测得线性范围８０～２５０μｇ／ｍＬ（ｒ＝０．９９９８），平均回收率１００．０％，ＲＳＤ０．３８％，最小检出量６．１２×１０－１２ｇ２０．４ｍｇ１００ｍＬ×１１００×０．３１００进样１μＬ．     

HPLC法测定丹膝颗粒中丹参酮Ⅱ_A的含量

目的建立测定丹膝颗粒中丹参酮ⅡA含量的HPLC法。方法采用HPLC法,色谱柱:AgilentEclipse XDB-C18(4.6 mm×150 mm,5μm);流动相:甲醇-水(80∶20);流速:1.0 mL/min;检测波长:270 nm;柱温:30℃。结果丹参酮ⅡA在0.020 50～0.820 0μg范围内与峰面积线性关系良好(r=0.999 9),平均回收率为99.76%,RSD=1.33%(n=6)。结论本方法专属性强、重复性好、结果准确可靠,可用于丹膝颗粒的质量控制和评价方法 。     

高效液相色谱法测定甲苯磺酸妥舒沙星的含量

建立了测定甲苯磺酸妥舒沙星含量的高效液相色谱法：ＡｌｌｔｉｍａＣ１８柱,０．１ｍｏｌ／Ｌ柠檬酸缓冲液（ｐＨ３．０）－乙腈（７５：２５）为流动相,检测波长为２５４ｎｍ,流速为１．０ｍｌ／ｍｉｎ。在２．５～１００ｐｇ／ｍｌ范围内线性关系良好;最低检测限为０．１μｇ／ｍｌ（Ｓ／Ｎ＝３）。     

基于指纹图谱分析和多成分同时定量的玉屏风丸质量评价

目的建立玉屏风丸的高效液相色谱(HPLC)指纹图谱,测定7种主要成分(毛蕊异黄酮葡萄糖苷、芒柄花素、升麻素苷、升麻素、白术内酯Ⅲ、白术内酯Ⅱ、白术内酯Ⅰ)的含量,为玉屏风丸的质量控制提供可靠方法。方法色谱柱为Shim-pack VP-ODS柱(250 mm×4.6 mm,5μm);流动相为乙腈(A)-0.3%磷酸溶液(B),梯度洗脱(0~20 min时12%A,20~40 min时12%A→35%A,40~46 min时35%A→68%A,46~50 min时68%A→80%A,50~60 min时80%A→12%A);流速为0.85 m L/min,检测波长升麻素苷为300 nm(0~20 min),毛蕊异黄酮葡萄糖苷和芒柄花素及升麻素为254 nm(20~40 min),白术内酯Ⅲ及白术内酯Ⅱ为220 nm(40~46 min),白术内酯Ⅰ为275 nm(46~60 min);柱温为35℃;流速为0.85 m L/min;进样量为10μL。结果玉屏风丸HPLC指纹图谱有18个共有峰,通过比较,指认其中7个指标成分,分别为4号(升麻素苷)、9号(毛蕊异黄酮葡萄糖苷)、10号(升麻素)、11号(芒柄花素)、16号(白术内酯Ⅲ)、17号(白术内酯Ⅱ)和18号(白术内酯Ⅰ),利用相似度软件对14批样品的指纹图谱进行分析,各批样品相似度均大于0.97。在建立的色谱条件下,7组分分离度良好,精密度和重复性试验的RSD均小于1.5%(n=6),供试品溶液在24 h内稳定,各成分具有良好的线性关系和较宽的线性范围。14批玉屏风丸中毛蕊异黄酮葡萄糖苷、芒柄花素、升麻素苷、升麻素、白术内酯Ⅲ、白术内酯Ⅱ、白术内酯Ⅰ质量浓度范围分别为1.5490~1.5640 mg/g,0.7015~0.7029 mg/g,0.7960~0.7977 mg/g,0.5905~0.5922 mg/g,0.6745~0.6762 mg/g,0.5210~0.5229 mg/g,0.3992~0.4015 mg/g。结论该建立的玉屏风丸HPLC指纹图谱检测和定量测定分析方法快速、准确,可有效评价玉屏风丸的质量。     

用高效毛细管电泳法分离六种肽类混合物的方法探讨

分高血管紧张素Ⅰ、Ⅱ、Ⅲ、Ｐ物质、神经激肽和生长激素释放的抑制因子等六种肽类混合物。方法：用胺基涂层毛细管［５７ ｃｍ×７５μｍ（ｉ．ｄ．）（有效长度为５０ｃｍ）〕,以４０ｍｍｏｌ／Ｌ醋酸铵（ｐＨ＝４．５）为运行缓冲液,在工作电压为 １０ ｋＶ、检测波长为 ２１４ ｎｍ、温度为 ２５℃的条件下对上述物质进行分离。结果：回收率及精密度均较好。结论;用带涂层的高效毛细管柱对肽类药物进行检测是较为理想的方法。     

HPLC测定冠心丹参滴丸中丹参酮Ⅱ_A的含量

目的建立冠心丹参滴丸中丹参酮ⅡA的含量测定方法。方法运用高效液相色谱法测定,色谱柱为ZORBAXXDB-C18(4.6mm×150mm,5μm),流动相:甲醇-水(80∶20),流速1ml.min-1,检测波长270nm,柱温:室温。结果丹参酮ⅡA在0.0458~0.1026μg范围内峰面积与测定量呈良好的线性关系,回归方程为Y=6.7426×103X-3.5967×102(r=0.9999),平均加样回收率为97.75%,RSD为1.81%(n=5)。结论本法灵敏,快速,准确,可用于测定冠心丹参滴丸中丹参酮ⅡA的含量。     

薄盖灵芝发酵菌丝体中主要核苷及其碱基的反相高效液相色谱测定

本文报道用反相高效液相色谱法测定薄盖灵芝发酵菌丝体中主要核苷及其碱基的含量。菌丝体用50%乙醇超声提取,脱脂后通过十八烷基键合相柱,用磷酸盐缓冲液(pH 6.98)—四氢呋喃(100:1)为流动相,对甲基苯磺酸为内标,峰面积内标法定量。方法灵敏、快速、重现性好,与薄层紫外法比较结果一致。